COVID VACCINE COVOVAX
Covid-19: DCGI approves market authorisation for Covovax as heterologous booster dose17 Jan, 2023, 08.41 AM IST
COVID-19 vaccination: NTAGI to review data of SII's vaccine 'Covovax'30 Mar, 2022, 12.59 PM IST
NTAGI approves Covovax Covid-19 vaccine for the 12-17 age group29 Apr, 2022, 10.04 PM IST
- Load More